Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Xtant Medical Holdings (XTNT) Change in Receivables (2016 - 2025)

Xtant Medical Holdings (XTNT) has disclosed Change in Receivables for 16 consecutive years, with -$1.2 million as the latest value for Q3 2025.

  • Quarterly Change in Receivables fell 120.36% to -$1.2 million in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $6.3 million through Sep 2025, up 244.85% year-over-year, with the annual reading at $755000.0 for FY2024, 91.36% down from the prior year.
  • Change in Receivables for Q3 2025 was -$1.2 million at Xtant Medical Holdings, down from $3.8 million in the prior quarter.
  • The five-year high for Change in Receivables was $3.9 million in Q3 2023, with the low at -$1.2 million in Q3 2025.
  • Average Change in Receivables over 5 years is $1.0 million, with a median of $903000.0 recorded in 2021.
  • The sharpest move saw Change in Receivables tumbled 215.61% in 2021, then skyrocketed 2068.06% in 2025.
  • Over 5 years, Change in Receivables stood at $903000.0 in 2021, then rose by 8.42% to $979000.0 in 2022, then soared by 72.52% to $1.7 million in 2023, then plummeted by 62.88% to $627000.0 in 2024, then plummeted by 296.81% to -$1.2 million in 2025.
  • According to Business Quant data, Change in Receivables over the past three periods came in at -$1.2 million, $3.8 million, and $3.1 million for Q3 2025, Q2 2025, and Q1 2025 respectively.